Theodore Halkias - Sep 14, 2021 Form 4 Insider Report for agilon health, inc. (AGL)

Role
Chief Business Officer
Signature
/s/ Lyn Amor Macaraeg, as Attorney-in-Fact
Stock symbol
AGL
Transactions as of
Sep 14, 2021
Transactions value $
-$4,536,313
Form type
4
Date filed
9/15/2021, 05:19 PM
Next filing
Dec 28, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGL Common Stock Options Exercise $58.6K +58.6K +1077.53% $1.00* 64K Sep 14, 2021 Direct F1
transaction AGL Common Stock Sale -$1.7M -58.6K -91.51% $28.98 5.43K Sep 14, 2021 Direct F1
transaction AGL Common Stock Sale -$2.9M -100K -100% $28.98 0 Sep 14, 2021 By trust F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGL Options (Rights to Buy) Options Exercise $0 -58.6K -3.25% $0.00 1.74M Sep 14, 2021 Common Stock 58.6K $1.00 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes restricted stock units.
F2 These shares of common stock were held in the Halkias Irrevocable Trust.
F3 These options were granted on April 27, 2017, and fully vested on May 15, 2017.